Liver Injury Induced by Herbal Extracts Containing Mistletoe and Kudzu
Publication: The Journal of Alternative and Complementary Medicine
Volume 21, Issue Number 3
Abstract
Purpose: Along with the use of herbal medicines worldwide, the number of cases of reported herbal-induced hepatotoxicity has also been increasing. This report describes a case of liver injury caused by mistletoe and kudzu extracts in a patient previously in good health.
Case: A 55-year-old man with no significant medical history was admitted to a hospital with a 10-day history of mild fever and brownish urine. The patient also had epigastric and right upper quadrant pain. The patient's liver function test results showed significantly elevated aspartate aminotransferase (AST) (958 IU/L) and alanine aminotransferase (ALT) (1000 IU/L) levels. Serologic viral hepatitis test results were negative. The patient neither consumed alcohol nor took any medications other than an antacid, which was not correlated with the elevated liver function test results. The patient reported taking mistletoe extract for 1 month and kudzu root extract for 10 days to promote his general health. Upon admission to the hospital, his AST and ALT levels were elevated to 1108 IU/L and 1528 IU/L, respectively. The total bilirubin level increased to 9.4 mg/dL on day 4. The modified Roussel Ulcaf Causality Assessment Method yielded a score of 10 points, indicating probable liver injury caused by mistletoe. Therefore, mistletoe- and kudzu-induced liver injury with a hepatocellular pattern was diagnosed. After discontinuation of the mistletoe and kudzu extracts in the hospital, the patient's liver function test values gradually decreased until day 8, with no other abnormal symptoms. The patient was discharged on hospital day 8 and had a follow-up visit at 1 week.
Conclusion: This case of liver injury characterized by a significant increase in AST and ALT levels was related to the use of mistletoe and kudzu extracts.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
National Institute Health's National Center for Complementary and Alternative Medicine (NCCAM). European mistletoe [homepage on Internet]. Online document at: http://nccam.nih.gov/sites/nccam.nih.gov/files/Herbs_At_A_Glance_European_Mistletoe_06-14-2012_0.pdf?nav=gsa, accessed June 26, 2014.
2.
Molassiotis A, Fernadez-Ortega P, Pud D, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 2005;16:655–663.
3.
Urech K, Scher JM, Hostanska K, Becker H. Apoptosis inducing activity of viscin, a lipophilic extract from Viscum album L. J Pharm Pharmacol 2005;57:101–109.
4.
Park JH, Hyun CK, Shin HK. Cytotoxicity of heat-treated Korean mistletoe. Cancer Lett 1998;126:43–48.
5.
Lyu SY, Park WB. Mistletoe lectin (Viscum album coloratum) modulates proliferation and cytokine expressions in murine splenocytes. J Biochem Mol Biol 2006;39:662–670.
6.
Ernst E. Mistletoe for cancer? Eur J Cancer 2001;37:9–11.
7.
Yoon TJ, Yoo YC, Choi OB, et al. Inhibitory effect of Korean mistletoe (Viscum album coloratum) extract on tumour angiogenesis and metastasis of haematogenous and non-haematogenous tumour cells in mice. Cancer Lett 1995;97:83–91.
8.
Gray AM, Flatt PR. Insulin-secreting activity of the traditional antidiabetic plant Viscum album (mistletoe). J Endocrinol 1999;160:409–414.
9.
Zhou YX, Zhang H, Peng C. Puerarin: a review of pharmacological effects. Phytother Res. 2014;28:961–975.
10.
Wong KH, Li GQ, Li KM, et al. Kudzu root: traditional uses and potential medicinal benefits in diabetes and cardiovascular diseases. J Ethnopharmacol 2011;134:584–607.
11.
Zhao Y, Zhou Y. Puerarin improve insulin resistance of adipocyte through activating Cb1 binding protein path. Chin J Integr Med 2012;18:293–298.
12.
Zhao M, Du YQ, Yuan L, Wang NN. Protective effect of puerarin on acute alcoholic liver injury. Am J Chin Med 2010;38:241–249.
13.
Liu CM, Ma JQ, Sun YZ. Puerarin protects the rat liver against oxidative stress-mediated DNA damage and apoptosis induced by lead. Exp Toxicol Pathol 2012;64:575–582.
14.
Zhang Z, Li S, Jiang J, et al. Preventive effects of Flos Perariae (Gehua) water extract and its active ingredient puerarin in rodent alcoholism models. Chin Med 2010;5:36.
15.
Peng JH, Cui T, Huang F, et al. Puerarin ameliorates experimental alcoholic liver injury by inhibition of endotoxin gut leakage, Kupffer cell activation, and endotoxin receptors expression. J Pharmacol Exp Ther 2013;344:646–654.
16.
McRae CA, Agarwal K, Mutimer D, Bassendine MF. Hepatitis associated with Chinese herbs. Eur J Gastroenterol Hepatol 2002;14:559–562.
17.
Nadir A, Agrawal S, King PD, Marshall JB. Acute hepatitis associated with the use of a Chinese herbal product, ma-huang. Am J Gastroenterol 1996;91:1436–1438.
18.
Jang JS, Seo EG, Han C, et al. [Four cases of toxic liver injury associated with Dictamnus dasycarpus]. Korean J Hepatol 2008;14:206–212.
19.
Shin HK, Jeong SJ, Leeb MS, Ernst E. Adverse events attributed to traditional Korean medical practices: 1999–2010. Bull World Health Organ 2013;91:569–575.
20.
Harvey J, Colin-Jones DG. Mistletoe hepatitis. Br Med J 1981;282:186–187.
21.
Kim SY, Yim HJ, Ahn JH, et al. [Two cases of toxic hepatitis caused by arrowroot juice]. Kor J Hepatol 2009;15:504–509.
22.
World Health Organization. The regional strategy for traditional medicine in the Western Pacific (2011–2020) [homepage on Internet]. 2002. Online document at: http://www.wpro.who.int/publications/2012/regionalstrategyfortraditionalmedicine_2012.pdf, accessed June 26, 2014.
23.
Navarro VJ. Herbal and dietary supplement hepatotoxicity. Semin Liver Dis 2009;29:373–382.
24.
Teschke R, Frenzel C, Glass X, et al. Herbal hepatotoxicity: a critical review. Br J Clin Pharmacol 2013;75:630–636.
25.
Teschke R, Wolff A, Frenzel C, et al. Herbal hepatotoxicity: a tabular compilation of reported cases. Liver Int 2012;32:1543–1556.
26.
Teschke R, Schulze J, Schwarzenboeck A, et al. Herbal hepatotoxicity: suspected cases assessed for alternative causes. Eur J Gastroenterol Hepatol 2013;25:1093–1098.
27.
Teschke R, Genthner A, Wolff A, et al. Herbal hepatotoxicity: analysis of cases with initially reported positive re-exposure tests. Dig Liver Dis 2014;46:264–269.
28.
Suk KT, Kim DJ, Kim CH, et al. A prospective nationwide study of drug-induced liver injury in Korea. Am J Gastroenterol 2012;107:1380–1387.
29.
Kim JB, Sohn JH, Lee HL, et al. ]Clinical characteristics of acute toxic liver injury]. Kor J Hepatol 2004;10:125–134.
30.
Wai CT, Tan BH, Chan CL, et al. Drug-induced liver injury at an Asian center: a prospective study. Liver Int 2007;27:465–474.
31.
Stripe F. Mistletoe toxicity. Lancet 1983;1;295.
32.
Kim BK, Choi MJ, Park KY, Cho EJ. Protective effects of Korean mistletoe lectin on radical-induced oxidative stress. Biol Pharm Bull 2010;33:1152–1158.
33.
Abdualmjid RJ. Sergi C. Hepatotoxic botanicals—an evidence-based systematic review. J Pharm Pharmaceut Sci 2013;16:376–404.
34.
van Wely M, Stoss M, Gorter RW. Toxicity of a standardized mistletoe extract in immunocompromised and healthy individuals. Am J Ther 1999;6:37–43.
35.
Tusenius KJ, Spoek AM, van Hattum J. Exploratory study on the effects of treatment with two mistletoe preparations on chronic hepatitis C. Arzneimittelforschung 2005;55:749–753.
36.
Kushner S, Han D, Oscar-Berman M, et al. Declinol, a complex containing Kudzu, bitter herbs (gentian, tangerine peel) and Bupleurum, significantly reduced Alcohol Use Disorders Identification Test (AUDIT) scores in moderate to heavy drinkers: a pilot study. J Addict Res Ther 2013;4: pii:.
37.
Bénichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol 1990;11:272–276.
38.
Danan G, Benichou C. Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993;46:1323–1330.
Information & Authors
Information
Published In
The Journal of Alternative and Complementary Medicine
Volume 21 • Issue Number 3 • March 2015
Pages: 180 - 185
PubMed: 25668233
Copyright
Copyright 2015, Mary Ann Liebert, Inc.
History
Published online: 11 March 2015
Published in print: March 2015
Published ahead of print: 10 February 2015
Topics
Authors
Author Disclosure Statement
No competing financial interests exist.
Metrics & Citations
Metrics
Citations
Export Citation
Export citation
Select the format you want to export the citations of this publication.
View Options
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.⚠ Society Access
If you are a member of a society that has access to this content please log in via your society website and then return to this publication.